Physician profile
Oren P Schaefer
NPI 1649252065
$3,929.34
in general payments reported to CMS, 2019-2025
21 companies · $1,015 in 2025
The $1,015 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $281 · 2021: $434 · 2022: $308 · 2023: $620 · 2024: $1,010 · 2025: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,410 · Education: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,409.96 |
| Education | $235.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,246.33 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $875.52 | 2019-2025 | Nucala, Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $178.98 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.81 | 2019-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $81.29 | 2025 | Opsynvi, Opsumit |
| Genzyme Corporation | $49.74 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.42 | 2024-2025 | Glassia |
| Amgen INC. | $34.00 | 2025 | |
| Insmed, INC. | $33.50 | 2025 | Brinsupri, Arikayce |
| Jazz Pharmaceuticals INC. | $31.50 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $30.85 | 2021-2025 | Dupixent |
| Baxter Healthcare | $29.36 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $27.04 | 2025 | Ohtuvayre |
| Pharming Healthcare, INC. | $26.38 | 2025 | Ruconest |
| Ars Pharmaceuticals Operations, INC. | $25.19 | 2025 | Neffy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $25.14 | 2022 | |
| Harmony Biosciences LLC | $24.18 | 2023 | Wakix |
| Allergan, INC. | $21.42 | 2020 | |
| Alk-Abello, INC | $15.06 | 2025 | Standardized Mite D. Farinae, Alternaria Tenuis, Timothy, Standardized |
| Pulmonx Corporation | $14.40 | 2020 | |
| Grifols USA, LLC | $14.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oren Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.